news

Our latest
Press Releases & Updates

Latest press releases

RetinAI will attend EURETINA 2022 from September 1st to 4th in Hamburg

RetinAI will attend the 22nd EURETINA Congress, from September 1st to 4th, at the CCH (Congress Centre Hamburg) in Hamburg, Germany. EURETINA 2022 attendees will get first-hand insights on the company’s two new products: Our new data management platform, Discovery CORE, designed to share data in a privacy-preserving and secure manner across a network of collaborators, fostering and facilitating knowledge network building, vendor-neutral collaborative data analysis & management, education, training and teleophthalmology. Our Disease Evaluation Apps on Heidelberg Engineering’s secure data workflow solution, called AppWay, for connecting to AI applications.
read more

RetinAI attends OIS Retina Innovation Summit and ASRS 2022 Annual Meeting from July 13th to 16th in New York

RetinAI will attend the OIS Retina Innovation Summit on July 13th at the Edison Ballroom NYC, and the ASRS 2022 Annual Meeting, from July 14th to 16th, at the Javits Convention Center in New York. ASRS attendees who visit RetinAI at Booth #625 will benefit from learning and seeing live demos on RetinAIs latest products and services.
read more

RetinAI announces multi-year software license and services agreement for RetinAI Discovery® UNITY platform

RetinAI announces a multi-year license and services agreement with Novartis AG (“Novartis”) for its Discovery® UNITY platform. Discovery UNITY is RetinAI’s top of the line enterprise-wide solution to aggregate imaging data for global organizations, including data from clinical and real-world evidence studies, with AI that can be applied to improve understanding of patient populations and outcomes at scale.
read more

RetinAI receives FDA Clearance for Discovery, our medical image & data management platform for Ophthalmology

RetinAI today announces U.S. Food and Drug Administration (FDA) 510(k) clearance of RetinAI Discovery®, the company’s image and data management platform for next-level interoperability across the clinical and clinical study ecosystems in Ophthalmology.
read more

Latest updates

RetinAI in RTS- Swiss television

The last week of August we received the Swiss Television (SRF - Schweizer Radio und Fernsehen) at our offices in Bern.We talked for a few minutes about what we do and how artificial intelligence is going to change ophthalmology and healthcare in the near future!
‍
Watch it here

Arvo 2019 - Vancouver [MAY’19]

RetinAI had a great conference at this year at ARVO 2019, with more than 15’000 attendees from all over the world!Congratulations to the team for these amazing 5 days of work and for the success on the official release of our two main products: OmniViewer and RetinAI Discovery.

Democratising Access to Health Care - INVESTIERE [APRIL’19]

"Automation does not replace jobs, it replaces tasks" - Learn how RetinAI applies machine learning to medical imaging, not to replace eye doctors, but to make their work less tedious. Via Investiere Venture Capital - Read more

RetinAI in FORBES FR [DECEMBER’18]

RetinAI is honoured to be in December's edition of Forbes France! Artificial Intelligence is changing the world of ophthalmology by democratising access to high-quality eye-care for everyone. Discover a bit more about the future of healthcare in 2019, starting with your eyes! [FR]

‍

Contact us for more informations! We are happy to hear from you!

Contact Us

Ikerian AG (HQ)
‍Freiburgstrasse 3
3010 Bern
Switzerland
‍

RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States

Certifications
SolutionS For
Life Sciences & Pharma
Clinics & Hospitals
Device Manufacturers
Products
DISCOVERY
- UNITY
- For Clinical Studies
- For Clinics
REAL WORLD EVIDENCE
APPS FOR CLINICS
PRECISION MEDICINE
Contact
info@retinai.com
Media kit
Careers
Product User Manual

Imprint/Legal Notice  |  Data Processing Agreement  |  Privacy Notice  |  Created by Ikerian AG. All rights reserved 2016-2023 ©